These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20172624)

  • 1. Individual drug sampling does not supplant the need for head-to-head trials in dermatology.
    Resneck JS; Vanbeek M
    J Am Acad Dermatol; 2010 Jun; 62(6):1062-3. PubMed ID: 20172624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug samples in dermatology: special considerations and recommendations for the future.
    Alikhan A; Sockolov M; Brodell RT; Feldman SR
    J Am Acad Dermatol; 2010 Jun; 62(6):1053-61. PubMed ID: 20172623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rise of the generic drug market and its implications for dermatology.
    Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
    J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rising drug costs: the impact on dermatology.
    Rico MJ
    Skin Therapy Lett; 2000; 5(4):1-2,5. PubMed ID: 10785406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of scientific evidence of risks and benefits in determining risk management policies for medications.
    Andrews E; Dombeck M
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):599-608. PubMed ID: 15362082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
    Manley HJ; Cannella CA
    Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Office of the Future Project: the integration of new technology into office practice. Academic detailing through the super highway. Quebec Research Group on Medication Use in the Elderly.
    Tamblyn RM; Jacques A; Laprise R; Huang A; Perreault R
    Clin Perform Qual Health Care; 1997; 5(2):104-8. PubMed ID: 10167210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A physician survey on generic drugs and substitution of critical dose medications.
    Banahan BF; Kolassa EM
    Arch Intern Med; 1997 Oct; 157(18):2080-8. PubMed ID: 9382664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
    Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
    Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
    Liu YM; Yang YH; Hsieh CR
    J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of the influence of prescription medicine samples on prescribing by family physicians.
    Hall KB; Tett SE; Nissen LM
    Med Care; 2006 Apr; 44(4):383-7. PubMed ID: 16565641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations before choosing (extemporaneously) compounded products.
    Krochmal L
    Dermatol Ther; 2009; 22(3):225-8. PubMed ID: 19453346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality circles to improve prescribing of primary care physicians. Three comparative studies.
    Wensing M; Broge B; Riens B; Kaufmann-Kolle P; Akkermans R; Grol R; Szecsenyi J
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):763-9. PubMed ID: 19507170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.